CompletedNot Applicable

Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial

China40 participantsStarted 2021-03-01

Plain-language summary

To observe the effect of micro-conjunctival autografting combined with amniotic membrane transplantation on the postoperative recurrence, complications and ocular surface symptoms among patients with recurrent pterygium.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age⩾18;
✓. relapsed after pterygium surgery once;
✓. invading the cornea 2.00\~5.00mm.

Exclusion criteria

✕. having obvious severe systemic organic diseases and mental diseases;
✕. In lactation or pregnancy or planned pregnancy;
✕. combined with eye diseases such as severe eyelid insufficiency, dry eye, chemical injury of cornea and conjunctiva, etc.;
✕. used drugs that may affect the growth and metabolism of corneal epithelium within four weeks before inclusion in the study;
✕. received pterygium surgery twice or more.

What they're measuring

Changes of grade of conjunctival hyperplasia

Timeframe: Day 0#3#7 and14, Month 1#3 and 6.

Changes of Schirmer test I

Timeframe: Day 0#3#7 and14, Month 1#3 and 6.

Changes of ocular surface symptom scores

Timeframe: Day 0#3#7 and14, Month 1#3 and 6.

Trial details

NCT IDNCT05362253

SponsorYifeng Yu

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-30

View on ClinicalTrials.gov More Recurrent Pterygium trials